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Abstract 
We report a rare case of a hemangioma arising from the accessory parotid gland. The patient, a 
45-year-old female, complained of a right mid-cheek mass. Magnetic resonance imaging (MRI) 
showed a well-defined mass located in the right buccal space, anterior to the masseter muscle 
and adjacent to Stensen’s duct. The mass had high T2-weighted signal intensity and showed 
strong patchy enhancement with gadolinium. This mass was surrounded by a common capsule 
with the accessory parotid gland. These findings indicated a hemangioma originating from the 
accessory parotid gland. The mass was completely removed by an intraoral approach without 
postoperative facial palsy, skin deformity, and difficulty in secreting saliva. Histological 
examination of the tumor revealed multiple, thin-walled, and dilated blood vessels, confirming 
the diagnosis of a cavernous hemangioma. MRI was extremely useful in diagnosing the mass as 
a hemangioma before surgery, clarifying relationships between the mass and adjacent structures 
and determining the surgical approach to the mass. 
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Introduction 
Neoplastic tumors originating in the accessory parotid gland are rare1,2,3. These tumors usually 
present as mid-cheek swelling, and surgical approaches are controversial. We report the case of 
a cavernous hemangioma arising from the accessory parotid gland, which was diagnosed by 
magnetic resonance imaging (MRI) before surgery. The tumor was successfully removed by an 
intraoral approach without postoperative complications. 
 
Materials and Methods 
A 45-year-old female visited our hospital complaining of a mass in her right mid-cheek. She 
was known to have had the mass for at least twenty years; its size increased gradually during 
this time. 
Physical examination revealed a firm, nontender, and mobile subcutaneous mass that was three 
centimeters in diameter (Fig. 1). Ultrasonography showed a comma-shaped mass with a 
well-defined margin separate from the parotid gland. The mass contained numerous small 
hypoechoic chambers, and vascular flow was identified on Doppler mode. No calcifications 
were present in the mass. On MRI (Fig. 2), a well-defined mass was located in the right buccal 
space, anterior to the masseter muscle and adjacent to Stensen’s duct. The mass was surrounded 
by a common capsule with the accessory parotid gland. It had low T1- and high T2-weighted 
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signal intensities. On gadolinium-enhanced T1-weighted images, the high intensity area spread 
in a patchy manner over time. Signal voids were not identified. These findings suggested that 
the mass was a hemangioma originating in the accessory parotid gland. Thus, we did not 
perform a fine needle aspiration biopsy of the mass. 
The operation was performed by an intraoral approach under general anesthesia with 
endotracheal intubation through the right nasal cavity. We used NIM-Response®2.0 (Medtronic 
Inc., Minneapolis, Minnesota) for nerve monitoring to ensure that the branches of the facial 
nerve were not injured. As a guide to prevent damage to the duct during surgery, a bougie was 
inserted into Stensen’s duct from its opening in the oral cavity. An incision was made on the 
right buccal mucosa. After cutting an anterior part of the buccinator muscle a dark blue mass 
was identified in the buccal space. This mass was successfully removed through the buccal 
mucosal incision without rupture of its capsule (Fig. 3). Stensen’s duct was preserved. Next, the 
borders of the incised buccinator muscle were sutured, after which the buccal mucosa was 
sutured. The operation lasted for sixty-seven minutes. The mass was dark red, comma-shaped, 
and 30 × 15 × 15 mm in size (Fig. 4). Histological examination of the mass revealed multiple, 
thin-walled, and dilated blood vessels, confirming the diagnosis of a cavernous hemangioma. 
The postoperative course was satisfactory and uncomplicated; facial palsy, skin deformity, and 
difficulty in secreting saliva were not observed. Three years later, there is no evidence of 




Hemangiomas originating in the accessory parotid gland are extremely rare2. To our 
knowledge, this is the second case of a hemangioma emerging from the accessory parotid gland 
in an adult and the first case to be treated by an intraoral approach. 
MRI is useful in demonstrating the extent of buccal space lesions4,5. Hemangiomas in the 
buccal space, reported in the literature, had high T2-weighted signal intensity and were 
enhanced by gadolinium4,5. In the present case, MRI revealed a mass with high T2-weighted 
signal intensity and strong patchy enhancement with gadolinium, indicating the presence of a 
hemangioma. Furthermore, MRI was useful for determining the surgical approach to the mass, 
clarifying relationships between the mass and adjacent structures such as Stensen’s duct and the 
masseter muscle. Fine needle aspiration biopsy is usually useful for the preoperative histological 
diagnosis of tumors in the head and neck regions. However, we consider it unnecessary when 
MRI strongly suggests that the tumor is a hemangioma. 
Generally, accessory parotid glands are located on the masseter muscle with the zygomatic and 
buccal branches of the parotid plexus of the facial nerve within the lobes and overlying them as 
a net-like covering6. Branches of the transverse facial artery are usually buried in the lobes of 
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the accessory glands6. Therefore, it is essential to understand this anatomy of the accessory 
parotid gland when determining a surgical approach to the mass in this area. 
Surgical approaches to tumors arising from the accessory parotid gland include a mid-cheek 
skin incision overlying the tumor1, an intraoral approach1,3, a parotidectomy-type incision 
without a parotidectomy1, a standard parotidectomy1, and a facelift approach2. In view of 
aesthetic results, the intraoral approach to the accessory parotid gland is better than the other 
approaches involving skin incisions although it is difficult to provide a good exposure for tumor 
resection. We believe that a benign vascular lesion, as that in the present study, can be a good 
candidate for an intraoral approach because it allows resection extremely close to its capsule and 
minimizes damage to adjacent structures such as the facial nerve, Stensen’s duct, and blood 
vessels. However, we do not recommend this approach when the tumor is preoperatively 
suspected to be a pleomorphic adenoma or malignant tumor because resection of such tumors 
generally requires a good exposure and sufficient surgical margins, and their capsules should 
not be ruptured during resection. 
We believe that the intraoral approach can be useful when the tumor meets the following 
conditions: 1. preoperative diagnosis as a benign vascular lesion such as a hemangioma, 2. not 
an extremely large size (<3 cm), and 3. located on the anterior portion of the masseter muscle 
(not too far from the buccal mucosa). Furthermore, it is ideal if nerve monitoring is performed 
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to avoid facial nerve injuries. 
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Fig. 1 Preoperative view. The dotted circle indicates tumor margins. 
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Fig. 2 MRI. (A) T2-weighted axial image. A well-defined mass with high signal intensity was 
located in the right buccal space anterior to the masseter muscle. The mass and Stensen’s duct 
(white arrows) were in contact with each other. (B) T2-weighted coronal image. The mass was 
surrounded by a common capsule with the accessory parotid gland (black arrows). (C) 
Gadolinium diethylenetriamine-pentaacetic acid enhanced the T1-weighted image with fat 
suppression. The mass showed a strong patchy enhancement. 
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Fig. 4 Macroscopic findings of the tumor. 
